The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a single-award, indefinite delivery contract to Cardinal Health, Inc. for radiopharmaceutical products. The potential value of the contract is $773,677.24 with a period of performance from February 22, 2022 to February 21, 2023.
Under this contract, Cardinal Health will provide radiopharmaceuticals to support medical imaging procedures for patients within the VA healthcare system. Specifically, the contract includes a $983,677.24 firm fixed price delivery order for radiopharmaceuticals with a period of performance from January 18, 2022 to January 18, 2023. Performance will take place in Dublin, Ohio. No set-asides or subcontractors were identified for this procurement.
As the largest integrated healthcare system in the United States, the VA relies on medical imaging technologies like positron emission tomography and single-photon emission computed tomography to diagnose and treat veterans. Through this contract vehicle, the VA aims to ensure a reliable supply of radiopharmaceuticals, which are radioactive tracers essential for performing these scans but have a limited shelf life, in support of its healthcare mission.
Generated 1/5/24, 5:55 PM